| Literature DB >> 27956476 |
C Doehring1, A Sundrum1.
Abstract
Homeopathy is widely used in livestock, especially in order to reduce the use of antibiotics, although it is often seen as controversial. A comprehensive literature review has been conducted to assess the efficacy of homeopathy in cattle, pigs and poultry. Only peer-reviewed publications dealing with homeopathic remedies, which could possibly replace or prevent the use of antibiotics in the case of infective diseases or growth promotion in livestock were included. Search results revealed a total number of 52 trials performed within 48 publications fulfilling the predefined criteria. Twenty-eight trials were in favour of homeopathy, with 26 trials showing a significantly higher efficacy in comparison to a control group, whereas 22 showed no medicinal effect. Cure rates for the treatments with antibiotics, homeopathy or placebo varied to a high degree, while the remedy used did not seem to make a big difference. Looking at all the studies, no study was repeated under comparable conditions. Consequently, the use of homeopathy currently cannot claim to have sufficient prognostic validity where efficacy is concerned. When striving for high therapeutic success in treatment, the potential of homeopathy in replacing or reducing antibiotics can only be validated if evidence of efficacy is confirmed by randomised controlled trials under modified conditions. British Veterinary Association.Entities:
Keywords: Caprine athritis encephalitis virus (CAEV); Goats; Risk factors; Seroprevalence
Mesh:
Year: 2016 PMID: 27956476 PMCID: PMC5256414 DOI: 10.1136/vr.103779
Source DB: PubMed Journal: Vet Rec ISSN: 0042-4900 Impact factor: 2.695
FIG 1:Search process for publications based on the PRISMA guidelines
FIG 2:Distribution of the indications in relation to the use of homeopathy
FIG 3:Quality of diagnostic measures
Number of trials and outcome regarding the efficacy of the homeopathic remedy applied
| Species | Number of trials | Efficacy | Inconclusive results | No efficacy |
|---|---|---|---|---|
| Cattle | 34 | 15 | 1 | 18 |
| Pigs | 12 | 9 | 1 | 2 |
| Poultry | 6 | 4 | 0 | 2 |
| Summary | 52 | 28 | 2 | 22 |
Cure rates for therapeutic use of different remedies
| Species | Indication | Recovery effect with | Author (year) | ||
|---|---|---|---|---|---|
| Homeopathy | Allopathy | Placebo | |||
| Cows | Mastitis | 34% a | 26% a | ||
| Cows | Mastitis | 34% a | 26% a | ||
| Cows | Mastitis | 33% a, o | 67% a, o | ||
| Cows | Mastitis | 19% a | 20% a | 6% a | |
| Cows | Mastitis | 47% b | 24% b | 30% b | |
| Cows | Mastitis | 5% a, g | 17% a, g | ||
| Cows | Mastitis | 63% e | 95% e | ||
| Calves | Diarrhoea | 83% l | 80% l | ||
| Calves | Diarrhoea | 69-77% i, m | 69% m | ||
| Sows | MMA | 61% m | 35% m | ||
a Full recovery=no pathological findings of milk and udder and negative cytobacteriological results of milk samples
b Full recovery=no pathological findings of milk and udder with negative bacteriological results of milk samples on first day of disease
c Full recovery=no pathological findings of milk and udder with positive bacteriological results of milk samples on first day of disease
d Clinical recovery=no pathological findings of milk and udder and with positive bacteriological or/and positive cytological results of milk samples
e Clinical recovery=no pathological findings of milk and udder
f Bacteriological recovery=negative bacteriological result of milk samples after treatment and negative California mastitis test
g Cows with clinical mastitis at minimum one udder quarter
h Cows without clinical signs, but positive bacteriological result of milk samples at minimum one udder
i Range of results due to the use of different homeopathic remedies
l Clinical recovery=change from watery to pasty faeces; animals treated by homeopathy recovered one day earlier
m Clinical recovery
n Bacteriological recovery=negative bacteriological result of milk samples after treatment
o Test group=cows with acute mastitis with disturbed general condition
p Test group=cows with acute mastitis without disturbed general condition
MMA Mastitis-metritis-agalactia syndrome
FIG 4:Study design and result for efficacy of homeopathy in the studies
Risk of bias
| Authors (year) | Randomised | Control | Blinding | Free from vested interest | Free of other shortcomings | Risk of bias |
|---|---|---|---|---|---|---|
| Y | AB | N | N | Potency unknown | High | |
| Y | AB, COM | N | U | N | High | |
| N | U | N | U | Intake unsure, some sows did not receive the full course of medication due to closeness to farrowing, only 20 animals considered | High | |
| N | U | N | U | Uneven distribution of animals | High | |
| Y | P | Y | U | Intake of medication unsure | Low | |
| N | U | N | U | Uneven distribution of cows, missing information on remedy | High | |
| Y | AB | N | U | Groups not completely randomised (grazing cows and farmer intervention) | High | |
| Y | CON | N | N | U | High | |
| N | N | N | U | U | High | |
| Drösemeier (1989) | Y | AB, P | Y | N | N | High |
| N | AB | N | U | Different times for follow-up checks | High | |
| Y | P | N | U | Uneven distribution, only 42 animals considered | High | |
| Y | AB, COM | N | U | Only 41 animals considered | High | |
| Y | P | N | U | Uneven distribution, 42 animals considered | High | |
| Schütte (1991) - trial 1 | Y | AB, P | N | U | U | High |
| Schütte (1991) - trial 2 | Y | P | N | U | U | High |
| N | P, U | Y | U | U | High | |
| Y | P | Y | U | Only 30 animals considered | Low | |
| Y | P | Y | U | 20 animals considered | Low | |
| Schütte (1994) - trial 1 | Y | P | Y | U | U | Low |
| Schütte (1994) - trial 2 | Y | P | Y | U | U | Low |
| N | N | N | U | 15 animals considered | High | |
| Y | P | N | U | 26 animals considered | High | |
| Y | P | Y | U | Only 10 animals considered | High | |
| Y | AB | N | U | U | High | |
| Albrecht and Schütte (1999) | Y | P, AB | N | N | U | High |
| Hümmelchen (1999) | Y | P | Y | N | U | High |
| Y | P | Y | U | U | Low | |
| Y | AB, P, COM | Y | N | U | High | |
| Schütte (2003) | N | N | N | U | U | High |
| Y | P, AB | Y | U | Unknown potency | Low | |
| Y | P | Y | N | 39 animals considered | High | |
| Y | P | Y | U | U | Low | |
| Y | U, AB | N | U | U | High | |
| N | U | N | U | Selective reporting (exclusion of ineffective remedies tested) | High | |
| Y | AB | N | N | U | High | |
| Y | CON | N | U | U | High | |
| Y | U, P | N | U | Uneven distributed initial weight | High | |
| Y | U | N | U | U | High | |
| Y | P | Y | N | U | High | |
| Y | AB | Y | U | 46 animals considered, AB known to be resistant to pathogen in trial | High | |
| Y | P | Y | U | U | Low | |
| Y | U, CON | N | N | U | High | |
| Y | P, AB | Y | U | U | Low | |
| N | N | N | U | Remedy data missing | High | |
| Y | AB | N | U | Potency unknown | High | |
| Kiarazm (2011) | Y | P | Y | U | Potency unknown | Low |
| Y | U, CON | N | U | Remedy data missing | High | |
| Y | P | Y | U | U | Low | |
| N | N | N | N | Researcher worked for supplier | High | |
| Y | P | Y | U | U | Low | |
| Y | AB | N | U | U | High |
AB Antibiotics, COM Combined treatment of homeopathy and antibiotics, CON Conventional treatment including antibiotics, N No, P Placebo, U Untreated, Y Yes
Publications on cattle
| Authors (year) | Species | Indication | Study design | Diagnostic measure | Effect of homeopathy? |
|---|---|---|---|---|---|
| Calves | Pneumonia / diarrhoea treatment | RCT non-blind | CS | IR: only vague improvement, no sign, differences between AB and HOM group | |
| Calves | Diarrhoea treatment | RCT non-blind | CS | No: repeated treatments necessary, more deaths, also no effect in combination with antibiotics | |
| Dairy cows | Postpartum disorders prevention | RCT non-blind | CS | Yes: no dead calf compared to untreated group (7 deaths). 2 of 7 cows (HOM) required assistance during birth and 18 of 18 in untreated. Fewer cases of mastitis/metritis in HOM (0/4) compared to untreated (9/10) | |
| Dairy cows | Mastitis prevention | RCT non-blind | CS | Yes: mastitis cases decreased (at high infection risk). Mastitis increased in untreated ‘low risk’ group | |
| Dairy cows | Mastitis prevention | RCT single-blind | CS | Yes: lower mastitis incidence compared to P | |
| Dairy cows | Mastitis (acute) Individualised treatment | RCT non-blind | DT/IT/CS | IR: no significant difference between HOM and AB treatments. | |
| Dairy cows | Mastitis prevention | Observational | CS | No: no preventive effect | |
| Dairy cows | Mastitis treatment | Observational | CS | Yes: good healing rates especially for | |
| Dairy cows | Retained placenta / endometritis metaphylaxis | RCT non-blind | IT/CS | Yes: occurence of endometritis and retained placenta significantly reduced compared to P | |
| Dairy cows | Mastitis treatment | RCT non-blind | DT/IT | No: no differences between HOM group, AB group and COM | |
| Dairy cows | Retained placenta / endometritis metaphylaxis | RCT non-blind | IT/CS | Yes: occurence of endometritis and retained placenta significantly reduced compared to P | |
| Dairy cows | Puerperal diseases & calf health (prevention) | Observational | CS | No: no differences to U and P | |
| Dairy cows | Parturition and puerperal disorders (prevention) | RCT double-blind | IT/CS/M | No: no influence compared to P | |
| Schütte (1994) – trial 1 | Dairy cows | Mastitis metaphylaxis | RCT single-blind | M | No: no difference between P and HOM |
| Schütte (1994) – trial 2 | Dairy cows | Retained placenta (prevention) | RCT single-blind | CS | No: no difference between a P and HOM |
| Dairy cows | Subclinical mastitis treatment | Observational | DT/IT | No: no response, mastitis even deteriorated. | |
| Dairy cows | Subclinical mastitis metaphylaxis | RCT non-blind | IT/M | Yes: 4.5 times less subclinical mastitis than in P group | |
| Hümmelchen (1999) | Dairy cows | Postpartum disorders (prevention) | RCT non-blind | DT/IT/CS/M | Yes: better development than P for birth, placenta retention, occurrence of mastitis other infections |
| Dairy cows | Mastitis metaphylaxis | RCT double-blind | DT/IT/CS | No: no prophylactic or therapeutic effect in comparison with AB dry off or P | |
| Calves | Diarrhoea treatment | RCT double-blind | CS/M | No: no difference in comparison to P | |
| Dairy cows | Clinical mastitis individualised treatment | RCT double-blind | CS | No: no efficacy beyond P or AB group. AB also comparably poor in effectiveness | |
| Dairy cows | Udder health (prevention) | RCT single-blind | DT/IT | Yes: improved health parameter compared to P | |
| Dairy cows | Mastitis prevention | RCT single-blind | IT | No: no significant differences between HOM and P on any sample day | |
| Dairy cows | Clinical and subclinical mastitis treatment | RCT non-blind | DT/IT/CS | No: no effect, only comparable with self-healing rates. AB in all cases more effective | |
| Dairy cows | Chronic endometritis treatment | Observational | IT/M | Yes: culling and conception rate improved, shorter interval until pregnancy, lower insemination index, higher first-service pregnancy rate. Comparable to hormone treatment, less effective than CON intrauterine treatment | |
| Dairy cows | Endometritis prevention | RCT double-blind | DT/IT | No: not effective in prevention or in enhancing reproductive performance | |
| Dairy cows | Mastitis prevention (at drying off) | RCT non-blind | DT/IT/CS | Yes: lower SCC and ‘normal milk secretion’ compared to U, but worse than teat sealer | |
| Dairy cows | Mastitis individualised treatment | RCT single-blind | DT/CS | Yes: positive over P group with mastitis, no difference to AB treatment after 4 and 8 weeks | |
| Dairy cows | Subclinical mastitis treatment | RCT single-blind | DT/IT | Yes: SCC and bacterial detection were significantly lower in HOM than P group after treatment (day 21 and 28) | |
| Dairy cows | Mastitis metaphylaxis | Observational | DT/IT | No: no improvement compared with U group | |
| Dairy cows | Early subclinical mastitis treatment | Observational | IT/M | Yes: significant reduction of electrical conductivity and increased milk yield 4 to 7 days after treatment | |
| Calves | Diarrhoea treatment | RCT double- blind | CS/M | No: No significant difference compared to P for all chosen parameters | |
| Dairy cows | Mastitis individualised treatment | RCT non-blind | CS | No: curing rate of antibiotics was significantly higher (no P or U group) |
AB Antibiotics, COM Combined treatment of homeopathy and antibiotics, CON Conventional treatment including antibiotics, CS Clinical signs, DT Direct test, HOM Homeopathy, IR Inconclusive results, IT Indirect test, M Measurements, P Placebo, RCT Randomised controlled trial, SCC Somatic cell count, U Untreated
Publications on pigs
| Authors (year) | Species | Indication | Study design | Diagnostic measure | Effect of homeopathy? |
|---|---|---|---|---|---|
| Sows | Stillbirth prevention | Observational | M | Yes: number of stillbirths decreased significantly compared to an untreated group | |
| Sows | MMA individualised treatment | RCT non-blind | CS/M | Yes: less treatments needed to recover compared to allopathy. Average treatment duration was slightly shorter. Higher litter weight and lower piglet mortality | |
| Drösemeier (1989) | Sows | MMA prevention | RCT double-blind | DT/CS/M | No: no difference on MMA infection rate compared to P or AB group |
| Schütte (1991) - trial 1 | Pigs | Respiratory tract diseases prevention | RCT non-blind | CS | Yes: HOM mix over 10 days lessens the sickness rate (18.1 per cent) in comparison to placebo (24,3 per cent), more effective than subtherapeutic AB dose (19.1 per cent) but less than therapeutic AB dose (10,4 to 8,3 per cent) |
| Schütte (1991) - trial 2 | Pigs | Respiratory tract diseases prevention | RCT non-blind | CS | Yes: HOM remedy had a significantly lower infection rate (17,7 per cent) than P (24,3 per cent) within a 5-day treatment double dosed |
| Sows | Growth promotion | RCT single-blind | M | No: no difference in birth weight of litters compared to P | |
| Albrecht and Schütte (1999) | Piglets | General and respiratory disease metaphylaxis | Observational | CS | Yes: significantly effective when compared with the P and routine low-dose AB for reduction of disease and prevention of respiratory diseases, but not better than a therapeutic dose of AB |
| Schütte (2003) | Pigs | Health in general | Observational | CS/M | Yes: AB use could be reduced by 60 per cent (over 3 years) on participating farms |
| Piglets | Post-weaning diarrhoea and weight loss prevention | RCT non-blind | M | IR: piglets treated with HOM had less weight loss as control group and less but not significant different to P. No statistical difference between food consumption or diarrhoea | |
| Piglets | RCT double-blind | CS/M | Yes: highest weight gain and significant reduction of diarrhoea compared to AB control (but medical agent of AB is known to have high resistance to | ||
| Piglets | RCT single-blind | DT/CS | Yes: less transmission and duration of disease shorter and less diarrhoea than in P group | ||
| Pigs | Growth promotion | Observational | M | IR: last of six measurements was higher, but at slaughter no significant weight differences found. Lack of a control group (and only five pigs per group) |
AB Antibiotics, COM Combined treatment of homeopathy and antibiotics, CON Conventional treatment including antibiotics, CS Clinical signs, DT Direct test, HOM Homeopathy, IR Inconclusive results, IT Indirect test, M Measurements, P Placebo, RCT Randomised controlled trial, U Untreated
Publications on poultry
| Authors (year) | Species | Indication | Study design | Diagnostic measure | Effect of homeopathy? |
|---|---|---|---|---|---|
| Chicken | Salmonellosis treatment | RCT non-blind | DT/CS | Yes: efficacy not significantly different to AB group | |
| Chicken | Observational | DT/CS/M | No: no difference compared to U control | ||
| Chicken | Salmonellosis (induced) prevention | RCT non-blind | DT | Yes: faecal excretion of S | |
| Chicken | Growth promotion | RCT non-blind | DT/M | No: no difference in growth speed or final weight compared to an untreated control | |
| Chicken | Growth promotion | RCT non-blind | DT/CS/M | Yes: higher growth rate, final weight and food conversion ratio compared to CON treatment (AB and vaccines) | |
| Chicken | Growth promotion and immune system improvement. | RCT double-blind | DT/CS/M | Yes: less mortality, increased productivity, a higher viability and a possible shunt to B lymphocyte activity and higher weight gain (only for females) than in U control |
AB Antibiotics, CON Conventional treatment including antibiotics, CS Clinical Signs, DT Direct Test, IT Indirect Test, M Measurements, RCT Randomised controlled trial, U Untreated